Normal view MARC view ISBD view

Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box. [electronic resource]

By:

Bliznakov, E G

Producer: 20020920Description: 56-9 p. digitalISSN:

0753-3322

Subject(s):

Online resources:

Available from publisher's website

In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 56

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8
9
10
11

1 Absenteeism. The disappearing act. Interview by Barbara Feiner.
by Imundo, L V
2 Sulfasalazine therapy for juvenile rheumatoid arthritis.
by Imundo, L F
3 Getting commitment by soliciting employee ideas.
by Imundo, L V
4 Silicone implants and autoimmune disease.
by Jacobs, J C
5 Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface.
by Imundo, L
6 Glomerulonephritis in a neonate with atypical congenital lupus and toxoplasmosis.
by Lam, C
7 High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
by Kimura, Y
8 Early versus later onset childhood-onset systemic lupus erythematosus: Clinical features, treatment and outcome.
by Hui-Yuen, J S
9 Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity.
by Hui-Yuen, J S
10 Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.
by Ardoin, S P
11 Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
by Schanberg, L E

Close